UBS AM
ABCL icon

UBS AM’s AbCellera Biologics ABCL Stock Holding History

UBS AM’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4M Sell
7,575,476
-301,153
-4% -$1.08M 0.01% 789
2025
Q4 		$26.9M Buy
+7,876,629
New +$35.2M 0.01% 757
2025
Q3 		– Sell
-8,471,619
Closed -$29.1M – 2273
2025
Q2 		$29.1M Sell
8,471,619
-7,199,444
-46% -$17.9M 0.01% 898
2025
Q1 		$34.9M Buy
15,671,063
+11,171,063
+248% +$32M 0.01% 764
2024
Q4 		$13.2M Sell
4,500,000
-90,103
-2% -$251K ﹤0.01% 1123
2024
Q3 		$11.9M Sell
4,590,103
-8,523
-0.2% -$23.6K ﹤0.01% 1147
2024
Q2 		$13.6M Buy
+4,598,626
New +$17.4M ﹤0.01% 1010
2022
Q3 		– Sell
-31,998
Closed -$341K – 2738
2022
Q2 		$341K Buy
+31,998
New +$271K ﹤0.01% 2434

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return